Mon. Jun 24th, 2024

Yth GK, Tan S-S, Thomas T, Scott HS: Molecular networks involved
Yth GK, Tan S-S, Thomas T, Scott HS: Molecular networks 5-HT1 Receptor Inhibitor medchemexpress involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling. Genome Biol 2009, ten:R104. Kopsida E, Stergiakouli E, Lynn PM, Wilkinson LS, Davies W: The part in the Y chromosome in brain function. Open Neuroendocrinol J 2009, two:200. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F: A model based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004, 99:90917. Smyth GK: Linear models and empirical bayes strategies for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, three: Article3. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003, four:P3. Fraser HB, Khaitovich P, Plotkin JB, Paabo S, Eisen MB: Aging and gene expression inside the primate brain. PLoS Biol 2005, three:e274.42. Duchon A, Raveau M, Chevalier C, Nalesso V, Sharp AJ, Herault Y: Identification with the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome 2011, 22:67484. 43. Saran N, Pletcher M, Natale J, Cheng Y, Reeves R: Worldwide disruption of your cerebellar transcriptome within a Down ULK2 Synonyms syndrome mouse model. Hum Mol Genet 2003, 12:2013019. 44. Mao R, Zielke C, Zielke H, Pevsner J: Global up-regulation of chromosome 21 gene expression in the building Down syndrome brain. Genomics 2003, 81:45767. 45. Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, Lehrach H, Reeves RH, Yaspo M-L: Transcript level alterations reflect gene dosage effects across various tissues inside a mouse model of down syndrome. Genome Res 2004, 14:1258267. 46. Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E: Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 2007, 17:66578. 47. Zembrzycki A, Griesel G, Stoykova A, Mansouri A: Genetic interplay among the transcription components Sp8 and Emx2 in the patterning in the forebrain. Neural Dev 2007, 2:8. 48. Dunty WC Jr, Kennedy MW, Chalamalasetty RB, Campbell K, Yamaguchi TP: Transcriptional profiling of Wnt3a mutants identifies Sp transcription things as necessary effectors from the Wnt/beta-catenin pathway in neuromesodermal stem cells. PLoS 1 2014, 9:e87018. 49. Mobley AK, Tchaicha JH, Shin J, Hossain MG, McCarty JH: Beta8 integrin regulates neurogenesis and neurovascular homeostasis inside the adult brain. J Cell Sci 2009, 122:1842851. 50. Vilardell M, Rasche A, Thormann A, Maschke-Dutz E, Perez-Jurado L, Lehrach H, Herwig R: Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects associated to neurological processes. BMC Genomics 2011, 12:229. 51. Hoeffer CA, Dey A, Sachan N, Wong H, Patterson RJ, Shelton JM, Richardson JA, Klann E, Rothermel BA: The Down syndrome vital region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J Neurosci 2007, 27:131613172. 52. Poppek D, Keck S, Ermak G, Jung T, Stolzing A, Ullrich O, Davies KJ, Grune T: Phosphorylation inhibits turnover from the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 2.